Simultaneous pancreas and kidney transplantation: current trends and future directions

RR Redfield, JR Scalea, JS Odorico - Current opinion in organ …, 2015 - journals.lww.com
Simultaneous pancreas and kidney transplantation: current tr... : Current Opinion in Organ
Transplantation Simultaneous pancreas and kidney transplantation: current trends and future …

First world consensus conference on pancreas transplantation: part II–recommendations

U Boggi, F Vistoli, A Andres… - American Journal of …, 2021 - Wiley Online Library
The First World Consensus Conference on Pancreas Transplantation provided 49 jury
deliberations regarding the impact of pancreas transplantation on the treatment of diabetic …

[HTML][HTML] Novel aspects of epitope matching and practical application in kidney transplantation

WH Lim, G Wong, S Heidt, FHJ Claas - Kidney international, 2018 - Elsevier
This review describes the recent developments in the applicability and clinical significance
of epitope matching in kidney transplantation. As incremental human leukocyte antigen …

Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants

A Koenig, CC Chen, A Marçais, T Barba… - Nature …, 2019 - nature.com
Current doctrine is that microvascular inflammation (MVI) triggered by a transplant-recipient
antibody response against alloantigens (antibody-mediated rejection) is the main cause of …

[HTML][HTML] De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients

H Kaneku, JG O'leary, N Banuelos, LW Jennings… - American Journal of …, 2013 - Elsevier
The role of de novo donor-specific HLA antibodies (DSA) in liver transplantation remains
unknown as most of the previous studies have only focused on preformed HLA antibodies …

[HTML][HTML] Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation

JG O'Leary, H Kaneku, N Banuelos… - American Journal of …, 2015 - Elsevier
Recent literature confirms donor-specific HLA alloantibodies (DSA) impair 5-year survival in
some but not all liver transplant recipients. In an effort to improve DSA testing's association …

Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients

LD Snyder, Z Wang, DF Chen, NL Reinsmoen… - Chest, 2013 - Elsevier
Background Long-term survival after lung transplant is limited by the development of chronic
and progressive airflow obstruction, a condition known as bronchiolitis obliterans syndrome …

Intermediate-term graft loss after renal transplantation is associated with both donor-specific antibody and acute rejection

JM DeVos, AO Gaber, LD Teeter, EA Graviss… - …, 2014 - journals.lww.com
Background Renal transplant recipients with de novo DSA (dDSA) experience higher rates
of rejection and worse graft survival than dDSA-free recipients. This study presents a single …

[HTML][HTML] Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes

SV Niederhaus, GE Leverson, DF Lorentzen… - American Journal of …, 2013 - Elsevier
Antibody-mediated rejection (AMR) after pancreas transplantation is a recently identified
entity. We describe the incidence of, risk factors for, and outcomes after AMR, and the …

Diagnosis and treatment of pancreas rejection

RR Redfield, DB Kaufman, JS Odorico - Current Transplantation Reports, 2015 - Springer
Despite significant improvement in pancreas allograft survival, rejection of the pancreas
remains a major clinical problem. In addition to cellular rejection of the pancreas, antibody …